Archives cystic-fibrosis

by in
Entry Author Date Location
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
San Diego’s Carolus Therapeutics Taps Advocate Group for R&D Support 08/27/13 San Diego
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
New Data Could Open Vertex’s CF Drug to 400 More Patients 07/29/13 Boston
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
PTC Therapeutics IPO Raises $125M Despite Checkered Past 06/20/13 New York
The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013 06/03/13 National
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
Will $28M in Debt Financing Push Good Start Genetics to Big Finish? 05/08/13 Boston
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
Can Biotech Learn From the TV Production Market? 04/26/13 National
Vertex Pharmaceuticals Booms on Cystic Fibrosis Combo Drug Study 04/18/13 Boston
InVitae, Led by Randy Scott, Goes ‘All-in’ For Genomic Diagnostics 01/18/13 San Francisco
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
Vertex Wins EU Approval for Cystic Fibrosis Drug 07/27/12 Boston
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
After Big Oops, Vertex Plows Ahead With Cystic Fibrosis Drug Combo 06/28/12 Boston
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Vertex, N-of-One, Flexion & More Boston Life Sciences News 06/01/12 Boston
Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data 05/29/12 Boston
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
Vertex Shares Boom on Cystic Fibrosis Results 05/07/12 Boston
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Page 2 of 5 « previous page · next page »